$8.61 Billion is the total value of Bellevue Group AG's 220 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 31.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ISRG | Buy | INTUITIVE SURGICAL INC | $187,062,000 | -10.9% | 620,068 | +6.1% | 2.17% | +0.3% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $173,349,000 | +37.7% | 3,913,947 | +32.0% | 2.01% | +55.1% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $129,839,000 | -9.1% | 1,116,508 | +17.6% | 1.51% | +2.4% |
| AXNX | Buy | AXONICS INC | $128,280,000 | +22.4% | 2,049,205 | +9.5% | 1.49% | +37.8% |
| SYK | Buy | STRYKER CORPORATION | $117,694,000 | +4.3% | 440,225 | +4.3% | 1.37% | +17.5% |
| PODD | Buy | INSULET CORP | $106,074,000 | +4.2% | 398,189 | +4.0% | 1.23% | +17.3% |
| AMED | Buy | AMEDISYS INC | $99,261,000 | +25.1% | 576,131 | +17.6% | 1.15% | +41.0% |
| OPCH | Buy | OPTION CARE HEALTH INC | $92,328,000 | +11.0% | 3,232,787 | +10.6% | 1.07% | +25.1% |
| OM | Buy | OUTSET MED INC | $91,579,000 | +254.4% | 2,017,159 | +259.8% | 1.06% | +299.6% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $89,929,000 | +20.8% | 1,151,159 | +39.2% | 1.04% | +36.1% |
| CDNA | Buy | CAREDX INC | $85,490,000 | +28.2% | 2,311,176 | +57.6% | 0.99% | +44.3% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $84,376,000 | +16.9% | 2,612,263 | +0.1% | 0.98% | +31.7% |
| INSM | Buy | INSMED INC | $83,467,000 | -13.0% | 3,551,776 | +0.9% | 0.97% | -2.0% |
| HCA | Buy | HCA HEALTHCARE INC | $75,235,000 | -0.5% | 300,197 | +2.0% | 0.87% | +12.1% |
| RDUS | Buy | RADIUS HEALTH INC | $73,454,000 | +36.6% | 8,318,714 | +7.1% | 0.85% | +54.0% |
| CI | Buy | CIGNA CORP NEW | $62,094,000 | +10.3% | 259,146 | +5.7% | 0.72% | +24.3% |
| ACCD | Buy | ACCOLADE INC | $59,380,000 | -17.2% | 3,381,507 | +24.3% | 0.69% | -6.6% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $55,825,000 | +81.5% | 1,098,712 | +68.9% | 0.65% | +104.4% |
| CNC | Buy | CENTENE CORP DEL | $55,619,000 | +2.3% | 660,635 | +0.1% | 0.65% | +15.2% |
| ABBV | Buy | ABBVIE INC | $50,497,000 | +21.5% | 311,500 | +1.5% | 0.59% | +36.9% |
| EXAS | Buy | EXACT SCIENCES CORP | $50,294,000 | +0.6% | 719,303 | +11.9% | 0.58% | +13.2% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $44,424,000 | +39.8% | 4,881,752 | +214.3% | 0.52% | +57.3% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $43,657,000 | -21.0% | 3,145,293 | +59.8% | 0.51% | -10.9% |
| SILK | Buy | SILK RD MED INC | $43,171,000 | +6.4% | 1,045,567 | +9.8% | 0.50% | +19.9% |
| BIO | Buy | BIO RAD LABS INCcl a | $40,558,000 | +35.3% | 72,009 | +81.5% | 0.47% | +52.4% |
| ATRC | Buy | ATRICURE INC | $39,310,000 | +13.4% | 598,605 | +20.1% | 0.46% | +27.7% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $38,219,000 | -10.4% | 11,078,003 | +1.8% | 0.44% | +0.9% |
| BAX | Buy | BAXTER INTL INC | $37,985,000 | -1.6% | 489,880 | +8.9% | 0.44% | +10.8% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $35,896,000 | +44.5% | 126,406 | +91.8% | 0.42% | +62.9% |
| HCM | Buy | HUTCHMED CHINA LTDsponsored ads | $33,123,000 | -12.3% | 1,750,690 | +62.6% | 0.38% | -1.0% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $29,784,000 | – | 2,405,825 | +100.0% | 0.35% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $29,779,000 | +20.9% | 719,482 | +10.4% | 0.35% | +36.2% |
| ILMN | Buy | ILLUMINA INC | $27,561,000 | -3.6% | 78,881 | +5.0% | 0.32% | +8.5% |
| CSTL | New | CASTLE BIOSCIENCES INC | $27,258,000 | – | 607,614 | +100.0% | 0.32% | – |
| NKTR | Buy | NEKTAR THERAPEUTICS | $25,917,000 | -56.9% | 4,808,401 | +8.0% | 0.30% | -51.5% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $23,987,000 | -21.7% | 660,069 | +0.4% | 0.28% | -11.7% |
| CVS | Buy | CVS HEALTH CORP | $23,517,000 | -0.4% | 232,355 | +1.6% | 0.27% | +12.3% |
| TXG | Buy | 10X GENOMICS INC | $19,235,000 | -44.5% | 252,859 | +8.7% | 0.22% | -37.5% |
| Buy | PROCEPT BIOROBOTICS CORP | $10,010,000 | +130.5% | 286,075 | +64.7% | 0.12% | +157.8% | |
| SGEN | Buy | SEAGEN INC | $7,260,000 | +2.1% | 50,400 | +9.6% | 0.08% | +15.1% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $6,079,000 | +17.7% | 124,961 | +3.1% | 0.07% | +34.0% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $5,944,000 | +72.9% | 89,600 | +51.9% | 0.07% | +97.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $5,752,000 | -8.8% | 74,600 | +4.5% | 0.07% | +3.1% |
| JNJ | Buy | JOHNSON & JOHNSON | $4,909,000 | +42.0% | 27,700 | +37.1% | 0.06% | +58.3% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $4,649,000 | -11.2% | 39,207 | +3.2% | 0.05% | 0.0% |
| DOCS | New | DOXIMITY INCcl a | $4,316,000 | – | 82,860 | +100.0% | 0.05% | – |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $3,525,000 | -0.5% | 111,700 | +27.7% | 0.04% | +13.9% |
| KOS | Buy | KOSMOS ENERGY LTD | $2,962,000 | +193.3% | 412,000 | +41.1% | 0.03% | +240.0% |
| CYTK | New | CYTOKINETICS INC | $2,540,000 | – | 69,000 | +100.0% | 0.03% | – |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $2,218,000 | -28.7% | 52,400 | +6.9% | 0.03% | -18.8% |
| SNY | New | SANOFIsponsored adr | $2,238,000 | – | 43,600 | +100.0% | 0.03% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $2,011,000 | – | 13,000 | +100.0% | 0.02% | – |
| ALKS | New | ALKERMES PLC | $1,973,000 | – | 75,000 | +100.0% | 0.02% | – |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $1,907,000 | – | 59,000 | +100.0% | 0.02% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $1,866,000 | +5.7% | 25,700 | +22.4% | 0.02% | +22.2% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $1,661,000 | -39.2% | 26,000 | +2.0% | 0.02% | -32.1% |
| PCRX | New | PACIRA BIOSCIENCES INC | $1,613,000 | – | 21,136 | +100.0% | 0.02% | – |
| CCCC | Buy | C4 THERAPEUTICS INC | $1,322,000 | -13.0% | 54,500 | +15.5% | 0.02% | -6.2% |
| KURA | New | KURA ONCOLOGY INC | $1,061,000 | – | 65,980 | +100.0% | 0.01% | – |
| NVCR | New | NOVOCURE LTD | $704,000 | – | 8,500 | +100.0% | 0.01% | – |
| GDX | New | VANECK ETF TRUSTgold miners etf | $514,000 | – | 13,400 | +100.0% | 0.01% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $432,000 | – | 16,000 | +100.0% | 0.01% | – |
| GOOG | New | ALPHABET INCcap stk cl c | $377,000 | – | 135 | +100.0% | 0.00% | – |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $65,000 | +54.8% | 619 | +78.9% | 0.00% | – |
| NIO | Buy | NIO INCspon ads | $23,000 | -8.0% | 1,093 | +40.1% | 0.00% | – |
| PDD | New | PINDUODUO INCsponsored ads | $19,000 | – | 466 | +100.0% | 0.00% | – |
| BILI | New | BILIBILI INCspons ads rep z | $19,000 | – | 744 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.